Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients
Objective. The study investigates the prostate-specific antigen threshold for adding targeted, software-based, magnetic resonance imaging-ultrasound fusion biopsy during a standard 12-core biopsy in biopsy-naïve patients. It secondarily explores whether the targeted biopsy is necessary in setting of...
Saved in:
| Main Authors: | Luke L. Wang, Brandon L. Henslee, Peter B. Sam, Chad A. LaGrange, Shawna L. Boyle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2021/5531511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
by: Yiji Peng, et al.
Published: (2025-03-01) -
Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01) -
Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators
by: Pengfei Jin, et al.
Published: (2025-12-01) -
Development of novel nomograms for predicting prostate cancer in biopsy-naive patients with PSA < 10 ng/ml and PI-RADS ≤ 3 lesions
by: Jia-gui Chai, et al.
Published: (2025-01-01) -
FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY
by: A. A. Keln, et al.
Published: (2018-01-01)